ARCHIVES

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

This article is from The Cancer Letter archive.

Vol. 34 No. 25 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Waxman urges drug companies to list clinical trials on NIH Web site.

June 18, 2004

FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”

July 21, 2006